May-22-24 08:00AM
May-10-24 04:36PM
03:15PM
May-09-24 11:55AM
08:05AM
06:59AM
Loading…
06:59AM
May-03-24 04:30PM
May-02-24 08:00AM
Apr-04-24 04:30PM
Feb-29-24 08:41AM
Feb-28-24 09:49PM
(Thomson Reuters StreetEvents) +13.58%
08:10AM
07:35AM
07:00AM
Feb-27-24 08:01AM
08:00AM
Loading…
Feb-21-24 08:00AM
Feb-20-24 10:00AM
Feb-01-24 08:00AM
Jan-05-24 08:01AM
Dec-01-23 04:30PM
(GlobeNewswire) +15.15%
+7.37%
Nov-08-23 02:42PM
12:13AM
(Thomson Reuters StreetEvents)
Nov-07-23 08:10AM
07:00AM
Oct-31-23 04:30PM
08:00AM
Sep-07-23 06:30AM
(American City Business Journals)
Sep-06-23 07:00AM
Aug-18-23 09:35AM
Aug-16-23 09:35AM
09:40AM
Loading…
Aug-08-23 09:40AM
08:00AM
Aug-04-23 04:05PM
Jul-28-23 10:13AM
03:14AM
Jul-27-23 09:34PM
01:44PM
(American City Business Journals)
07:06AM
Jul-13-23 09:45AM
Jul-06-23 04:05PM
Jun-22-23 11:04AM
Jun-16-23 10:43AM
02:26AM
Jun-15-23 09:32AM
07:36AM
07:30AM
Jun-13-23 06:00AM
Jun-02-23 04:05PM
May-28-23 09:06AM
May-24-23 08:00AM
May-09-23 08:35AM
07:00AM
May-04-23 04:05PM
May-03-23 08:00AM
May-02-23 08:00AM
Apr-26-23 04:05PM
Apr-19-23 02:42PM
Apr-17-23 11:07AM
Apr-06-23 04:05PM
Apr-05-23 02:00PM
Mar-16-23 11:20AM
Mar-13-23 02:00PM
07:54AM
07:30AM
Mar-10-23 07:10PM
Mar-03-23 04:05PM
Mar-02-23 08:55PM
Mar-01-23 05:24AM
Feb-28-23 11:51PM
(Thomson Reuters StreetEvents) +11.60%
07:00AM
Feb-21-23 08:00AM
Feb-03-23 04:05PM
Feb-02-23 08:00AM
Feb-01-23 08:00AM
Jan-25-23 08:00AM
Jan-20-23 03:16PM
Jan-16-23 02:18AM
Jan-06-23 04:05PM
07:00AM
Dec-31-22 07:42AM
Dec-23-22 12:46PM
(American City Business Journals)
10:08AM
Dec-22-22 04:08PM
04:05PM
Dec-14-22 08:00AM
Dec-02-22 04:05PM
Nov-08-22 08:00AM
Nov-07-22 08:25AM
07:00AM
Nov-04-22 04:05PM
Oct-31-22 08:00AM
Oct-30-22 10:13AM
Oct-17-22 09:40AM
Oct-06-22 04:05PM
Oct-04-22 04:05PM
(GlobeNewswire) +10.44%
+9.59%
Sep-30-22 08:02AM
Sep-12-22 08:00AM
Sep-06-22 08:00AM
Sep-02-22 04:05PM
Sep-01-22 10:17AM
Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of antibody-drug conjugates that offer clinical benefit for cancer patients. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592. The company was founded by Mikhail Papisov in 2001 and is headquartered in Cambridge, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Protopapas Anna Director Jan 16 '24 Sale 2.71 29,399 79,671 125,153 Jan 17 05:21 PM Lowinger Timothy B SVP, Chief Sci.&Tech. Officer Jan 16 '24 Sale 2.71 10,409 28,208 199,329 Jan 17 05:19 PM DeSchuytner Brian SVP, COO & CFO Jan 16 '24 Sale 2.71 9,327 25,276 54,511 Jan 17 05:18 PM Mandelia Ashish VP, Chief Accounting Officer Jan 16 '24 Sale 2.71 5,025 13,618 23,328 Jan 17 05:20 PM Carvajal Alejandra SVP, Chief Legal Officer Jan 16 '24 Sale 2.71 4,381 11,873 27,403 Jan 17 05:18 PM Bala Mohan SVP, Chief Development Officer Jan 16 '24 Sale 2.71 3,431 9,298 14,052 Jan 17 05:16 PM MISRA TUSHAR SVP, Chief Manuf. Officer Jan 16 '24 Sale 2.71 3,357 9,097 17,966 Jan 17 05:21 PM Lowinger Timothy B SVP, Chief Sci.&Tech. Officer Jan 15 '24 Option Exercise 0.00 15,208 0 209,738 Jan 17 05:19 PM DeSchuytner Brian SVP, COO & CFO Jan 15 '24 Option Exercise 0.00 10,208 0 63,838 Jan 17 05:18 PM Protopapas Anna Director Jan 15 '24 Option Exercise 0.00 38,958 0 154,552 Jan 17 05:21 PM Mandelia Ashish VP, Chief Accounting Officer Jan 15 '24 Option Exercise 0.00 5,352 0 28,353 Jan 17 05:20 PM Mandelia Ashish VP, Chief Accounting Officer Jan 14 '24 Option Exercise 0.00 4,783 0 23,001 Jan 17 05:20 PM MISRA TUSHAR SVP, Chief Manuf. Officer Jan 14 '24 Option Exercise 0.00 1,458 0 21,323 Jan 17 05:21 PM Protopapas Anna Director Jan 14 '24 Option Exercise 0.00 16,750 0 115,594 Jan 17 05:21 PM Carvajal Alejandra SVP, Chief Legal Officer Jan 14 '24 Option Exercise 0.00 2,500 0 31,784 Jan 17 05:18 PM DeSchuytner Brian SVP, COO & CFO Jan 14 '24 Option Exercise 0.00 6,250 0 55,630 Jan 17 05:18 PM Lowinger Timothy B SVP, Chief Sci.&Tech. Officer Jan 14 '24 Option Exercise 0.00 4,792 0 194,530 Jan 17 05:19 PM Lowinger Timothy B SVP, Chief Sci.&Tech. Officer Jan 13 '24 Option Exercise 0.00 9,375 0 189,738 Jan 17 05:19 PM DeSchuytner Brian SVP, COO & CFO Jan 13 '24 Option Exercise 0.00 10,000 0 47,380 Jan 17 05:18 PM Carvajal Alejandra SVP, Chief Legal Officer Jan 13 '24 Option Exercise 0.00 8,958 0 29,284 Jan 17 05:18 PM Bala Mohan SVP, Chief Development Officer Jan 13 '24 Option Exercise 0.00 8,750 0 17,483 Jan 17 05:16 PM Protopapas Anna Director Jan 13 '24 Option Exercise 0.00 31,250 0 98,844 Jan 17 05:21 PM MISRA TUSHAR SVP, Chief Manuf. Officer Jan 13 '24 Option Exercise 0.00 7,083 0 19,865 Jan 17 05:21 PM Mandelia Ashish VP, Chief Accounting Officer Jan 13 '24 Option Exercise 0.00 2,645 0 18,218 Jan 17 05:20 PM Bala Mohan SVP, Chief Development Officer Oct 26 '23 Sale 1.13 1,912 2,161 8,733 Oct 27 04:07 PM Bala Mohan SVP, Chief Development Officer Oct 25 '23 Option Exercise 0.00 6,250 0 10,645 Oct 27 04:07 PM MISRA TUSHAR SVP, Chief Manuf. Officer Aug 17 '23 Sale 1.18 1,908 2,251 11,507 Aug 18 04:01 PM MISRA TUSHAR SVP, Chief Manuf. Officer Aug 16 '23 Option Exercise 0.00 6,250 0 13,415 Aug 18 04:01 PM